Podcasts about resistant hypertension

Is Renal Denervation the Cure for Hypertension? Discover Who Really BenefitsIn this Hypertension Resistant to Treatment episode, we discuss renal denervation and early study results. Tune in for information on the right patient for this procedure and what primary care providers, specialists, and care teams should know before making a referral.Join us as we explore:Patient selection criteria – What makes someone an ideal candidate for renal denervation?Interviews with interventional specialists – Hear from providers who perform renal denervation and how they assess patients.Perspectives from treating providers – Learn how post-procedure care and monitoring are managed in real-world practice.Patient stories – Real experiences from individuals who have undergone the procedure: what changed, what didn't, and what they wish they knew beforehand.Whether you're a primary care provider, cardiologist, nephrologist, or just curious about the evolving treatment landscape for hypertension, these episodes are packed with insights, clinical pearls, and practical takeaways.

Treat Hypertension Like No Doctor Has Ever Treated Hypertension Before Treating hypertension never gets boring. Learn about emerging therapies and how to continue to tackle this common diagnosis like a pro.  Dr. Jordy Cohen (@jordybc.bsky.social) leads us through her approach to keeping the BP where it should be (University of Pennsylvania). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Introduction and Current Interests 01:55 Understanding Hypertension 11:59 Blood Pressure Measurement Techniques 19:58 Treatment Goals and Guidelines for Hypertension 30:02 Managing Resistant Hypertension and New Treatments 36:00 Exploring GLP-1 Agonists and Blood Pressure Benefits 39:06 Aldosterone Synthase Inhibitors: A New Hope 42:00 Innovative Approaches: Small Interfering RNAs in Hypertension 47:06 Renal Denervation: A Controversial Procedure 55:01 Understanding Resistant Hypertension and Testing Protocols Credits Writer and Producer: Deborah Gorth MD, PhD Show Notes: Ben Furman and Deborah Gorth MD, PhD Cover Art and Infographic: Deborah Gorth MD, PhD and Meryl Gorth RD, MPH Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai Achi MD, MBA, FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Jordana Cohen MD, MSCE Disclosures Dr. Jordana Cohen and The Curbsiders report no relevant financial disclosures.  Sponsor: Factor Eat smart with Factor. Get started at factormeals.com/factorpodcast and use code FACTORPODCAST to get 50% off your first box plus free shipping.  Sponsor: CME Meeting  Visit www.CMEmeeting.org/curbsiders to save 30% on all online courses and live webcasts with promo code CURB30. Sponsor: Panacea Financial Explore financial solutions designed to make your life better at panaceafinancial.com. 

LATE BREAKING CLINICAL SCIENCE: CT-Guided Ozone-Mediated Renal Denervation Treating Resistant Hypertension

How Often Should You Monitor Blood PressureSend us a text Support the showSupport the podcast by subscribing using this link: click here. We appreciate your support, thank you! Need help with your Blood Pressure Management? Click this link for a Telehealth visit.Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your healthcare provider for medical advice. All views and statements in this podcast are those of the host, guest, and speakers.The views and opinions expressed on this podcast are my own and do not represent the official position or policies of my employer or any affiliated organization. Any information shared here is intended for educational and informational purposes only, based on my personal expertise and research.

Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP-CBlood Pressure Control: Expert Tips for Home Blood Pressure Monitoring Welcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge to successfully guide patients to obtain good blood pressure control. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.Pubmed Research GateResearch SymposiumSend us a text Support the showSupport the podcast by subscribing using this link: click here. We appreciate your support, thank you! Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your healthcare provider for medical advice. All views and statements in this podcast are those of the host, guest, and speakers.

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Miguel Camafort from Barcelona. They discuss his approach to the diagnosis and management of resistant hypertension. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful. Link to published paper: https://heart.bmj.com/content/early/2023/12/21/heartjnl-2022-321730

Send us a textTonya Breaux-Shropshire, PhD, DNP, MPH, FNP-CNatural Way to Lower Blood Pressure.Welcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.NP's: Need Help Managing Your Patient's Resistant Hypertension? Enrollment will open up again on May 15, 2024! Sign up at this link. Support the showSupport the podcast by subscribing using this link. Thank you!: https://www.buzzsprout.com/765992/subscribeCopyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your healthcare provider for medical advice. All views and statements in this podcast are those of the host, guest, and speakers.

Send us a textDiabetes Prevention: Unbelievable Research Findings for Prediabetics.Welcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.NP's: Need Help Managing Your Patient's Resistant Hypertension? Enrollment will open up again on May 15, 2024! Sign up at this link.  Support the showCopyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your healthcare provider for medical advice. All views and statements in this podcast are those of the host, guest, and speakers.

Send us a textNew Markers of Resistant Hypertension Identified in Black Patients. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

Send us a Text Message.Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP, Host-Primary Care Eye Exam: Importance of the Fundoscope Exam  Welcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly new nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.NP's: Need Help Managing Your Patient's Resistant Hypertension? Enrollment will open up again May 15, 2024! Sign up at this link  Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP, Host-How Thyroid Cysts Could Be Secretly Fueling Your High Blood PressureWelcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly new nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.NP's: Need Help Managing Your Patient's Resistant Hypertension? Enrollment will open up again May 15, 2024! Sign up at this link Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP, Host-Understanding the Stages of Change for Blood Pressure ManagementWelcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly new nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.NP's: Need Help Managing Your Patient's Resistant Hypertension? Enrollment will open up again May 15, 2024! Sign up at this link  Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP, Host-Unraveling the White Coat Effect and White Coat Hypertension for NPsWelcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly new nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.****We want to thank all of our sponsors for their generous support. Click here to support this podcast. Many thanks for tuning in.References-2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) The Cardiovascular Risk of White-Coat Hypertension (https://www.sciencedirect.com/science...) Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

Reason for Visit: JT was referred by his PCP to the ambulatory care pharmacist for hypertension management. Chief complaint: “My medication is making my mouth dry. I want to stop it.” Guest Authors: Sabrina Silviera, PharmD and Megan Scalia, PharmD, BCACP Expert Panelists: Eric MacLaughlin, PharmD, BCPS and Joseph Saseen, PharmD, BCPS, BCACP, CLS Music by Good Talk

Speaker: Glen Henry, MD; Medical Director, Cath Lab, Georgia Heart Institute Sanjay Lall, MD, MBA, FACC; Cardiologist; Georgia Heart Institute Speakers have no disclosures Objectives: • Discuss the burden and impact of hypertension. • Discuss the definition and diagnostic evaluation of hypertension. • Discuss the treatment of hypertension.

In this episode, Drs. Leslie Davis and Margaret "Midge" Bowers discuss how to diagnose and treat resistant hypertension. To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center, then enter the participation code and complete the post-test and evaluation. This podcast was made possible by an independent medical education grant from Medtronic.    

Hypertension FAQ Round #2 Dr. Jordy Cohen Strikes Back Tackle resistant hypertension. Learn when it is pseudo resistant hypertension, and how to treat this pesky condition when it is true resistant hypertension. Dr. Jordy Cohen (@jordy_bc) leads us through her approach to keeping the BP where it should be (University of Pennsylvania). Claim free CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | YouTube | Mailing List | Contact | Swag! | CME Show Segments Intro Case Hypertension definition Mechanisms of hypertension Vascular stiffness and aging Antihypertensive agents Anxiety and hypertension Escalating blood pressure management Resistant hypertension Ruling out pseudo resistant hypertension Substance induced pseudo resistant hypertension Pick of the Week Outro Credits Written and Produced by: Deborah Gorth MD, PhD Infographic and Cover Art: Deborah Gorth MD, PhD and Meryl Gorth Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD, MBA Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Jordy Cohen MD, MSCE Sponsor: Indeed Visit Indeed.com/INTERNALMEDICINE to start hiring now Full transcript available HERE

Learn about the diagnosis and treatment of resistant hypertension (also called apparent treatment resistant hypertension) from guest Vivek Bhalla, MD. What is the prevalence of this disease? What does the screening process look like, and what does the research support in terms of guideline-directed medical therapy?AHA Scientific Statement on Resistant Hypertension:https://www.ahajournals.org/doi/10.1161/HYP.0000000000000084 Cost Effectiveness Screening PA & Resistant Hypertension, Lubitz, et. al. https://pubmed.ncbi.nlm.nih.gov/26555126/ Primary Aldosteronism Foundation: https://www.primaryaldosteronism.org/ Stanford Hypertension Center: https://med.stanford.edu/hypertension.html The Endocrine Society: PA Screening https://www.endocrine.org/news-and-advocacy/news-room/featured-science-from-endo-2021/few-patients-at-risk-for-common-high-blood-pressure-disorder-receive-screeningSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Speaker: Hadia Ahmad, MD IM Resident PGY-3 No Disclosures Objectives: •Define treatment resistant hypertension. •Understand the role of endothelin and aldosterone in the pathophysiology of hypertension. •Recognize the endothelin pathway as a target for treatment of resistant hypertension. •Review current research investigating endothelin-receptor antagonists and aldosterone synthase in the treatment of hypertension.

Electrophysiologist Dr. Heberton addresses clinicians about compelling data presented at American Heart Association Scientific Sessions in 2022 indicating the importance of providers making early identification of atrial fibrillation and referring to specialists for better long-term outcomes.  Earlier treatment reduces the risk of disease progression and repeat hospitalization.

Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found at The Lancet. His op-ed for InSight+ is free to access and can be found here. With MJA news and online editor Cate Swannell.

CME credits: 1.25 Valid until: 23-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/resistant-hypertension-key-takeaways/14371/ In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

CME credits: 1.25 Valid until: 23-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/sustained-blood-pressure-lowering-effect-with-the-dual-endothelin-receptor-antagonist-aprocitentan-in-resistant-hypertension-results-from-a-randomized-controlled-study-including-a-withdrawal-phase/14370/ In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

CME credits: 1.25 Valid until: 21-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/bringing-it-all-together-how-to-manage-the-faces-of-resistant-hypertension/14807/ When patients present with resistant hypertension, clinicians aim to stabilize blood pressure by adding or replacing traditional agents, then hope that noncompliance and reduced adherence won't further complicate management. Fortunately, new and effective pharmacologic treatments, device therapies and multidisciplinary team approaches are rapidly changing outcomes. This CE-certified symposium will assess diagnostic delay consequences, traditional treatment shortfalls, dual endothelin-receptor antagonists and why guidelines don't keep pace with real-world clinical practice.

CME credits: 1.25 Valid until: 21-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/what-are-the-faces-of-resistant-hypertension/14805/ When patients present with resistant hypertension, clinicians aim to stabilize blood pressure by adding or replacing traditional agents, then hope that noncompliance and reduced adherence won't further complicate management. Fortunately, new and effective pharmacologic treatments, device therapies and multidisciplinary team approaches are rapidly changing outcomes. This CE-certified symposium will assess diagnostic delay consequences, traditional treatment shortfalls, dual endothelin-receptor antagonists and why guidelines don't keep pace with real-world clinical practice.

CME credits: 1.25 Valid until: 21-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/new-modalities-and-moas-for-resistant-hypertension/14802/ When patients present with resistant hypertension, clinicians aim to stabilize blood pressure by adding or replacing traditional agents, then hope that noncompliance and reduced adherence won't further complicate management. Fortunately, new and effective pharmacologic treatments, device therapies and multidisciplinary team approaches are rapidly changing outcomes. This CE-certified symposium will assess diagnostic delay consequences, traditional treatment shortfalls, dual endothelin-receptor antagonists and why guidelines don't keep pace with real-world clinical practice.

CME credits: 1.25 Valid until: 21-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/does-the-precision-trial-change-the-landscape-of-resistant-hypertension/14801/ When patients present with resistant hypertension, clinicians aim to stabilize blood pressure by adding or replacing traditional agents, then hope that noncompliance and reduced adherence won't further complicate management. Fortunately, new and effective pharmacologic treatments, device therapies and multidisciplinary team approaches are rapidly changing outcomes. This CE-certified symposium will assess diagnostic delay consequences, traditional treatment shortfalls, dual endothelin-receptor antagonists and why guidelines don't keep pace with real-world clinical practice.

In this week's podcast, John Mandrola, MD, discusses the PROTECTED TAVR trial, renal denervation, left atrial appendage closure and deprescribing aspirin. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Cerebral Embolic Protection After TAVI - Clear Stroke Benefit Eludes Embolic Protection: PROTECTED TAVR https://www.medscape.com/viewarticle/980978 - Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement https://www.nejm.org/doi/10.1056/NEJMoa2204961 - Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement https://doi.org/10.1016/j.jacc.2016.10.023 - Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa1908655 - Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2208681 - Randomised Trial Of Intravenous Streptokinase, Oral Aspirin, Both, Or Neither Among 17 187 Cases Of Suspected Acute Myocardial Infarction: Isis-2 https://doi.org/10.1016/S0140-6736(88)92833-4 II Renal Denervation - Legacy of Neutral Renal Denervation Trial Recast by Long-term Outcomes: SYMPLICITY HTN-3 https://www.medscape.com/viewarticle/981062 - Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial https://doi.org/10.1016/S0140-6736(22)01787-1 - A systematic review, meta-analysis, and meta regression of the sham controlled renal denervation randomized controlled trials https://doi.org/10.1016/j.tcm.2022.05.009 - Legacy of Neutral Renal Denervation Trial Recast by Long-term Outcomes: SYMPLICITY HTN-3 https://www.medscape.com/viewarticle/981062 - A Controlled Trial of Renal Denervation for Resistant Hypertension https://www.nejm.org/doi/10.1056/NEJMoa1402670 III Percutaneous Left Atrial Appendage Occlusion (LAAO) - Amulet, Watchman 2.5 LAAO Outcomes Neck and Neck at 3 Years https://www.medscape.com/viewarticle/981199 - Consider Life Expectancy When Referring for LAA Closure? https://www.medscape.com/viewarticle/981117 - Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure https://www.jacc.org/doi/full/10.1016/j.jacep.2022.06.012 IV Deprescribing Aspirin - Deprescribing Aspirin for Warfarin Patients May Reduce Bleeding https://www.medscape.com/viewarticle/981243 - Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796492 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Learn about resistant hypertension's presence in America and how it can be prevented or addressed from Dr. Power in today's podcast. Listen and learn!

tbd

tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/the-endothelin-et-system-and-its-role-in-resistant-hypertension/14225/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/how-will-the-game-change-with-the-entry-of-new-agentsmoasdifferent-pharmacokinetics-for-resistant-hypertension/14227/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/what-new-therapies-drugs-and-devices-are-on-the-horizon-for-resistant-hypertension/14226/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/hypertension-vs-resistant-hypertension-what-are-the-key-differences/14219/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/clinical-practice-guidelines-for-resistant-hypertension-what-are-recommendations/14223/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/gi-insights/what-does-a-typical-resistant-hypertension-patient-look-like/14222/ tbd

How High Blood Sugar Increases Your Blood Pressure. In this episode, I will tell you how high blood sugars could be keeping your blood pressure elevated. Share this information to help your family and friends! Thanks for listening!See the related video at this link (Length=1 min):   https://youtu.be/W8mVfol88iw Basal Metabolic Index Calculator (also known as body mass index-BMI)Click here if you need a telehealth appointment with a certified medical doctor.*****Read about Vitamins D and K's effect on blood pressure here. *Vitamin D HOME TESTING KIT here (levels here) ***Ask your doctor about any of the following vitamins or supplements:Vitamin C with rose hips, Zinc, D3 & K2, Magnesium or this one, B complex, and NAC.****Hi, I'm Dr. Tonya Breaux-Shropshire, a clinical research scientist who shares everything about hypertension and trending health topics so you can get good blood pressure control.  You can read my work HERE.****lResources:Michael Greger, MD FACLM, Nutritional Facts Centers for Disease ControlCheung BM, Li C. (2012)Forslund et al. (2015)Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Intro by Mr. Willie Breaux, Jr.****Disclaimer: This podcast is not medical advice, consult your health care provider.

Happy Holidays! In this podcast we review CME articles on Adhesive Capsulitis and Resistant Hypertension. We also discuss articles on re-evaluation of race in the GFR calculation, as well as a case of metabolic acidosis induced by a ketogenic diet. As the year comes to a close, and we take a moment for reflection and gratitude, we would like to thank YOU, our listeners, for your continued support. We hope you enjoy our holiday bonus episode as a token of our gratitude. We look forward to producing more episodes in the new year!By the way... are you following JAAPA on social media? Their Instagram handle is @jaapaonline. Let us know your thoughts on the topics we discussed in the comments section, under the articles we reviewed.  JAAPA Instagram: https://www.instagram.com/jaapaonline/ Thanks for listening! 

In Part 2 of our Resistant Hypertension videos, I'm looking at hyperaldosteronism, or high aldosterone levels, as a cause for treatment-resistant hypertension — and an underrecognized one at that. So what is high aldosterone? Where does it come from? When do you check for it? What causes it? If a patient has high aldosterone, what do you do next? Let's dig in!Note that assessing for this may be out of your practice comfort zone — and that's totally fine! But it's still important to know what hyperaldosteronism means for your patients. In this video, I touch on:✅ What distinguishes primary and secondary aldosteronism - and why it matters✅ Symptoms to keep an eye on when looking at the different ideologies for high aldosterone✅ And how to navigate that always-tricky dance of testing and referral as a nurse practitionerLooking for more guidance on CKD? Get on the waitlist for our upcoming chronic care course at https://www.realworldnp.com/courses — registration opens this fall! See acast.com/privacy for privacy and opt-out information.

Resistant hypertension is a common chief complaint in primary care clinics. But for new nurse practitioners, there's a lot to sort through. In this video, I walk through the thought processes and approaches to managing resistant hypertension in primary care. ✅ How to talk about medication adherence with patients✅ The role of ongoing blood pressure checks — both in clinic and at home✅ Considerations for current medications and dosing✅ How to investigate the secondary causes of hypertensionStressed about labs? Watch our free Top Three Mistakes Even Smart NPs Make Interpreting Labs training at https://realworldnp.com/training See acast.com/privacy for privacy and opt-out information.

Ultrasonic Nerve Destruction Treats Drug-Resistant Hypertension Vidcast:  https://youtu.be/5fSwIDc3Tcs   Zapping nerves entering the kidneys with pulsed ultrasound can significantly lower elevated blood pressures in those who fail traditional drug therapy with a triple combination medication.  An international, multi-center study headed by Columbia University researchers enrolled 136 patients, and 69 of them underwent ultrasound renal denervation with the 67 controls undergoing sham procedures.   The ultrasound treated group enjoyed a significant 5.8 mmHg blood pressure reduction compared with the controls.  There were no significant complications from the procedure.   Larger clinical trials will be needed to confirm the safely and effectiveness of ultrasound renal nerve ablation.  If proven effective, ultrasound will be added to radiofrequency energy as a means of renal nerve ablation.   https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00788-1/fulltext   #hypertension #ultrasound #renalnerve  

Dr. Centor discusses the importance of considering primary aldosteronism in patients with resistant hypertension with Dr. Jordana Cohen from the University of Pennsylvania.

The president's supporters may have stormed the capitol and attempted a coup today, but the show must go on. Today I'm joined by Dr. Dani Babbel to talk about treatment of hypertension in the hospital, as well as testing for primary aldosteronism in patients with resistant hypertension. Check it out! Treatment and Outcomes in Inpatient Hypertension Testing for Primary Aldosteronism and MRA Use Among US VeteransTocilizumab in Hospitalized Patients with COVID-19Music from https://filmmusic.io"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)License: CC BY (http://creativecommons.org/licenses/by/4.0/)

In this episode you will hear what Resistant Hypertension is and how it is connected to Lupus. Also I discuss Diet and Lupus, I know you have heard this a thousand times but just listen to how changing up what you consume how it can benefit your overall health. Please go over to my YouTube Channel and subscribe and like. You Can Follow Me On IG: @iamlupus IG:@mystorylivingwithlu FB: Susan Hendrix Sponsors Promo Code: suelynne1 Promo Link: https://goli.com/suelynne1 Tubbuddy Affiliate Code mystorylivingwithlupuspod Affiliate Link https://www.tubebuddy.com/mystorylivingwithlupuspod #lupus #resistanthypertension #mystorylivingwithlupuspodcast --- Send in a voice message: https://anchor.fm/susan-hendrix/message

Did you know that about 5-10% of patients with resistant hypertension have a secondary cause that is potentially curable? In this episode, we cover how to work-up a patient for secondary hypertension as well as which patients to suspect a secondary cause. Further, we discuss management of both resistant and secondary hypertension! Listen to our podcast on adrenal incidentalomas as an adjunct!Written by: Dr. Claudia Frankfurter (IM resident)Reviewed by: Dr. Paula Harvey (Cardiology) and Dr. Tom MacMillan (GIM)

A panel of experts discusses a patient case of CKD and resistant hypertension, and strategies to manage hyperkalemia to improve outcomes. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/930455?src=mkm_podcast_addon_930455

What you don't know about these two blood pressure drugs might hurt you. In this episode, Dr. Tonya will tell you what you might not know about two drugs that are commonly used to treat severe hypertension. Here is what everybody ought to know about Clonidine and Hydralazine. The information in this podcast is based on the current hypertension guidelines, the Physician Desk Reference, and Dr. Tonya's clinical experiences. This is not medical advice. Consult with your doctor or health care provider for any medical advice.Click here to see how to use a home blood pressure monitor and log.You can purchase an Omron Blood Pressure Monitor from any big box store or pharmacy. Click here for purchase online.About the host: Dr. Tonya is a clinical research scientist at the University of Alabama at Birmingham, Alabama, where she holds various positions. She spent the past decade studying home blood pressure monitoring and tracking, medication adherence, readiness, and confidence to change lifestyle behaviors. She is the author of six first-authored publications in scientific journals. She has collaborated with her colleagues on three published studies with the finding from the landmark Systolic Blood Pressure Intervention (SPRINT) Trial. You can read her peer-reviewed research studies at https://www.ncbi.nlm.nih.gov/pubmed/?term=TONYA+BREAUX-SHROPSHIRE.About the podcast: Dr. Tonya has created this blog and podcast for everyday people to learn what everybody ought to know about hypertension. Uncontrolled hypertension is a leading cause of stroke, kidney failure, heart attack, congestive heart failure, and other poor cardiovascular outcomes. With this podcast, Dr. Tonya hopes to decrease health disparity and improve health literacy in the cardiovascular space. Before you can take control of your health and health care costs, you have to invest your time in learning what you ought to know about hypertension. Hit the subscribe button to get upcoming episodes immediately when released. Share Hypertension Resistant to Treatment blog and podcast with any one person who would benefit from it.If you enjoyed the podcast, please share and consider leaving a 5-star rating and leave a short review below.Resources:Hypertension GuidelinesPhysician Desk Reference Voiceover Intro and soon to be outro done by Mr. Willie Breaux, Jr.Song: Forget Your Feet; Artist: Tayler Watts; Licensed to YouTube by Epidemic Sound; Epidemic Sound PublishingDisclaimer: This podcast is for information purposes only and should not be used as medical advice. It is for educational purposes only and was not intended to replace medical advice. Dr. Tonya has provided this content based on her research training and clinical and research knowledge. Consult your health care provider for medical advice.

Welcome back to the podcast! Sorry for scratchy voice and no intro - doing this from home recovering from illness.  Today we tackle the dreaded resistant hypertension - what causes it, what not to miss, what to do, and what probably doesn't matter. 

I am very excited about having today's guest on Hypertension Resistant To Treatment. Dr. Judd is an Associated Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB). He is the Associate Program Director for the Nephrology Fellowship at UAB and the Co-module director for the renal module at UAB's School of Medicine. He has research interests in delaying the progression of chronic kidney disease and the treatment of difficult-to-control hypertension. He was a writing member for the American Heart Association's scientific statement on resistant hypertension in 2018. He sees patients in a hypertension clinic at UAB.Dr. Judd will talk about resistant hypertension: What it is, how it is treated, associated risk factors, how to prevent it, and he will give a couple of patient examples of resistant hypertension and more.Ready, let’s do this!For more help to reduce your blood pressure, go to hypertensiontesistantotreatment.comAbout the host: Dr. Tonya is a clinical research scientist at the University of Alabama at Birmingham, Alabama, where she holds various positions. She spent the past decade studying home blood pressure monitoring and tracking, medication adherence, readiness, and confidence to change lifestyle behaviors. She is the author of six first-authored publications in scientific journals. She has collaborated with her colleagues on three published studies with the finding from the landmark Systolic Blood Pressure Intervention (SPRINT) Trial. You can read her peer-reviewed research studies at https://www.ncbi.nlm.nih.gov/pubmed/?term=TONYA+BREAUX-SHROPSHIRE.About the podcast: Dr. Tonya has created this blog and podcast for everyday people to learn what everybody ought to know about hypertension. Uncontrolled hypertension is a leading cause of stroke, kidney failure, heart attack, congestive heart failure, and other poor cardiovascular outcomes. Before you can take control of your health and health care costs, you have to invest your time in learning what you ought to know about hypertension. Hit the subscribe button to get upcoming episodes immediately when released. Share Hypertension Resistant to Treatment blog and podcast with any one person who would benefit from it.What else do you want to know about hypertension? What should Dr. Tonya talk about next? Please let her know in the comments below. If you enjoyed the podcast, please consider leaving a 5-star rating and leave a short review below.Voiceover Intro and soon to be outro done by Mr. Willie Breaux, Jr.Song: Forget Your Feet; Artist: Tayler Watts; Licensed to YouTube by Epidemic Sound; Epidemic Sound PublishingDisclaimer: This podcast is for information purposes only and should not be used as medical advice. It is for educational purposes only and was not intended to replace medical advice. Dr. Tonya has provided this content based on her research training and clinical and research knowledge. Consult your health care provider for medical advice and treatment and before starting any nutritional supplements or lifestyle practice.

We all know that hypertension is a significant risk factor for cardiovascular disease and stroke. I have two questions for you. Did you know that most of the decisions your doctor makes about your hypertension treatment are based on your 10-year cardiovascular risk score? What are your chances of having a heart attack or stroke within the next ten years? Dr. Tonya will tell you how to calculate your 10-year cardiovascular risk score, why it is essential to understand, and how to improve your score. According to extensive research that has been done since the 1960s, this calculation is fairly reliable if you are between 40-79 years old, have cholesterol less than 320, and without a history of cardiovascular disease. Quote: "You cannot change how someone thinks, but you can give them a tool to use which will lead them to think differently". ~R. Buckminster Fullerhttp://www.cvriskcalculator.com/Voiceover Intro and soon to be outro done by Mr. Willie Breaux, Jr.Song: Forget Your Feet; Artist: Tayler Watts; Licensed to YouTube by Epidemic Sound; Epidemic Sound PublishingAbout the host: Dr. Tonya is a clinical research scientist at the University of Alabama at Birmingham, Alabama, where she holds various positions. She spent the past decade studying home blood pressure monitoring and tracking, medication adherence, readiness, and confidence to change lifestyle behaviors. She is the author of six first-authored publications in scientific journals. She has collaborated with her colleagues on three published studies with the finding from the landmark Systolic Blood Pressure Intervention (SPRINT) Trial. You can read her peer-reviewed research studies at https://www.ncbi.nlm.nih.gov/pubmed/?term=TONYA+BREAUX-SHROPSHIRE.Dr. Tonya has created this blog and podcast for everyday people to learn what everybody ought to know about hypertension. Follow and send her a message or question on Facebook or Twitter. Subscribe and share her blog or podcast with any one person who could benefit from it.Join me every week for more hypertensionresistattotreatment.com podcast, and hit subscribe to get upcoming episodes immediately when released. Disclaimer: This podcast is for information purposes only and should not be used as medical advice. It is for educational purposes only and was not intended to replace medical advice. Dr. Tonya has provided this content based on her research training and clinical and research knowledge. Consult your health care provider for medical advice and treatment and before starting any nutritional supplements or lifestyle practice.

On this episode, we discuss a few tips and tricks for treating resistant hypertension that can be utilized before adding additional medications. We review the recently published article on bedtime dosing for antihypertensive medications as well as several others.  If you have any questions for myself or Cole, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Luke Laffin, MD, Medical Director of Cardiac Rehabilitation and cardiologist in the Section of Preventive Cardiology at Cleveland Clinic talks about two related abstracts recently presented at the American Heart Association’s Hypertension Scientific Sessions focused on resistant hypertension in a cardiac rehabilitation program. Dr. Laffin defines resistant hypertension, the prevalence of resistant hypertension in a cardiac rehabilitation setting, factors associated with patients who have resistant hypertension, and lessons learned about this patient population.

Luke Laffin, MD, Medical Director of Cardiac Rehabilitation and cardiologist in the Section of Preventive Cardiology at Cleveland Clinic talks about two related abstracts recently presented at the American Heart Association’s Hypertension Scientific Sessions focused on resistant hypertension in a cardiac rehabilitation program. Dr. Laffin defines resistant hypertension, the prevalence of resistant hypertension in a cardiac rehabilitation setting, factors associated with patients who have resistant hypertension, and lessons learned about this patient population.

Listen to our first ever discussion with @kidney_boy, Joel Topf MD. It’s a classic episode with a fresh intro as we prepare for @NephMadness 2019 with our friends from Twitter and @AJKDonline Dominate leg cramps, diuretic therapy, and resistant hypertension with tips from @kidney_boy, Joel Topf MD @kidney_boy, Chief of Nephrology Kashlak Memorial Hospital, co-creator @NephMadness. We start with basic renal physiology and build up to the treatment of resistant hypertension. Corrections: Dr Topf posted the following corrections on his blog PBfluids.com 3/22/2017 “I enjoyed the experience immensely, but in an hour of talking off the cuff I made some embarrassing mistakes: In describing water reabsorption I said it occured in the cortical collecting duct rather than the medullary collecting duct. In describing my cure for cramps I tell the story of Gitelman’s and say it is like congenital loop diuretics rather than congenital thiazide diuretics I mucked up the story about the MRFIT story and how it allowed a head to head comparison of HCTZ and chlorthalidone. I really oversold what happened.”   Full show notes at https://thecurbsiders.com/podcast. Join our newsletter mailing list. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com. Credits Written by: Matthew Watto MD Produced by: Stuart Brigham MD and Matthew Watto MD Cohosts: Stuart Brigham MD and Matthew Watto MD Guest: Joel Topf MD Sponsor Get your ACP membership today and use the code CURB100 to save $100 when you join by March 31, 2019. Time Stamps 00:00 Sponsor - Become a member of the American College of Physicians 00:28 Disclaimer, Intro, Recap of upcoming shows, Corrections and Omissions 05:50 Guest one-liner, Discussion of social media in medical education, Joel’s book 12:45 Twitter for medical education including NephJC and NephMadness 19:50 Sponsor - Become a member of the American College of Physicians 21:30 Intro to diuretics, mechanism of action and a brief review of renal physiology 28:26 Use of thiazide diuretics 30:18 Chlorthalidone versus hydrochlorothiazide 34:47 Diuretics and hyponatremia, Monitoring electrolytes and renal function on diuretics 39:05 Leg (muscle) cramps and pickle juice 42:55 Thiazides, osteoporosis and fracture prevention 45:32 Resistant hypertension and  the workup for secondary hypertension 53:36 Loop diuretics: how to choose an agent, dosing 62:15 Take home points 67:00 Outro

JP Milon is CEO of Paris-based Quantum Genomics, a company developing a treatment for patients with hypertension that is resistant to currently available medications.  Over-represented in populations with resistant hypertension, minorities often suffer severe complications as a result of having perpetual high blood pressure.  JP discusses firibastat, Quantum Genomic's experimental drug which works by acting on the part of the brain that lowers blood pressure and could potentially help these under-served patients. #hypertension  #cardiology  #treatmentresistance #biotech Quantum Genomics  

Resistant hypertension is a common problem faced by both primary care clinicians and specialists. John Szawaluk, MD, discusses treatment protocols and when a specialist referral is necessary. Resistant hypertension occurs in approximately 20-30 percent of individuals with high blood pressure and is a common problem faced by both primary care clinicians and specialists. John Szawaluk, MD, discusses treatment protocols and when a specialist referral is necessary.

Today on MedNet21, we're going to discuss Resistant Hypertension.

Dominate leg cramps, diuretic therapy, and resistant hypertension. Our guest, Dr. Joel Topf, is a clinical nephrologist, pioneer in the use of social media for medical education, and Assistant Clinical Professor at Oakland University William Beaumont School of Medicine, best known for his blog, Precious Bodily Fluids, and hilarious/informative Twitter feed @kidney_boy. We start with basic renal physiology and build up to the treatment of resistant hypertension. For full show notes visit http://thecurbsiders.com/podcast. Join our newsletter mailing list. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com. Tags: assistant, care, diuretics, doctor, education family, foam, foamed, health, hospitalist, hospital, hypertension, internal, internist, nephrology, nurse, media, medicine, medical, physician, physiology, practitioner, primary, social, renal, resident, resistant, student  

In this concise talk, Dr. Jan Basile covers resistant hypertension including 24-hour ambulatory measurements, workup for secondary causes and evidence for pharmacologic treatments.   Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page. Disclaimers

This week, we debut our new “Two Truths, One Lie” segment! Join us and put your knowledge to the test. As always, Amol, general internal medicine resident at the University of Toronto, and Reena, staff physician at St. Michael's hospital, discuss 2 recent papers: A multi-centred cross over trial conducted in the UK tried to ... The post Old Questions, New Options: Spironolactone for Resistant Hypertension and Polymer-Free Stents appeared first on Healthy Debate.

This week, we debut our new “Two Truths, One Lie” segment! Join us and put your knowledge to the test. As always, Amol, general internal medicine resident at the University of Toronto, and Reena, staff physician at St. Michael's hospital, discuss 2 recent papers: A multi-centred cross over trial conducted in the UK tried to ...The post Old Questions, New Options: Spironolactone for Resistant Hypertension and Polymer-Free Stents appeared first on Healthy Debate.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 04, 2014 issue

Dr. Christodulos Stefanadis. Advances in Renal Artery Denervation for the Treatment of Resistant Hypertension and Other Cardiovascular Diseases. Recorded 2013-10-28.